NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20254246

Company海南赛立克药业有限公司

Registration Date

May 27, 2025

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（按C₂₀H₂₅ClN₂O₅计）

Drug Type

化学药品

Registration Date

May 27, 2025

Company Information

Applicant Company

Company Name海南赛立克药业有限公司

Company Address

海口市美兰区顺达路6号

Manufacturing Company

Company Name海南赛立克药业有限公司

Company Address

海口市美兰区顺达路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath